10004 Results for "

full

" in MedChemExpress (MCE) Product Catalog:
Products (10004)

10004 Results for "full" in MCE Product Catalog:

18
18 Publications Verification
Cat. No.: HY-19620
CAS No.: 1562338-42-4
Synonyms: LMI070; NVS-SM1
Research Areas:  

Cancer

Branaplam (LMI070; NVS-SM1) is a highly potent, selective and orally active survival motor neuron-2 (SMN2) splicing modulator with an EC50 of 20 nM for SMN. Branaplam inhibits human-ether-a-go-go-related gene (hERG) with an IC50 of 6.3 μM. Branaplam elevates full-length SMN protein and extends survival in a severe spinal muscular atrophy (SMA) mouse model .
loading...
    loading...
18
18 Publications Verification
Cat. No.: HY-19620A
CAS No.: 1562338-39-9
Synonyms: LMI070 hydrochloride; NVS-SM1 hydrochloride
Research Areas:  

Cancer

Branaplam (LMI070; NVS-SM1) hydrochloride is a highly potent, selective and orally active survival motor neuron-2 (SMN2) splicing modulator with an EC50 of 20 nM for SMN. Branaplam hydrochloride inhibits human-ether-a-go-go-related gene (hERG) with an IC50 of 6.3 μM. Branaplam hydrochloride elevates full-length SMN protein and extends survival in a severe spinal muscular atrophy (SMA) mouse model .
loading...
    loading...
18
18 Publications Verification
Cat. No.: HY-123942
CAS No.: 2170867-89-5
Purity:  98.82%
Diprovocim is a potent TLR1/TLR2 agonist. Diprovocim elicits full agonist activity in human THP-1 cells (EC50=110 pM). Diprovocim stimulates the release of TNF-α from mouse macrophages (EC50=1.3 nM). Diprovocim activates downstream MAPK and NF-κB signaling pathway. Diprovocim displays strong adjuvant activity in mice, particularly abetting cellular immune responses .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-RI04602
Target:  

MicroRNA

Research Areas:  

Others

MicroRNA Inhibitor Negative Control is a full-length nucleotide 2'-methoxy modified oligonucleotide, and can be used as a negative control. The sequence of MicroRNA Inhibitor Negative Control is derived from cel-mir-239b. It has minimal sequence identity with miRNAs in human, mouse, and rat.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-10629
CAS No.: 875787-07-8
Purity:  99.95%
Synonyms: WAY 252623
Target:  

LXR

Research Areas:  

Metabolic Disease Cancer

LXR-623 is a brain-penetrant partial LXRα and full LXRβ agonist, with IC50s of 24 nM and 179 nM, respectively.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-12342
CAS No.: 1430213-30-1
Purity:  99.89%
Synonyms: CID-49852229
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

ML216 (CID-49852229) is a potent, selective and cell permeable inhibitor of the DNA unwinding activity of BLM helicase with IC50s of 2.98 μM and 0.97 μM for BLM full-length and BLM 636-1298, respectively. ML216 inhibits ssDNA-dependent ATPase activity of BLM with a Ki of 1.76 μM. Antitumor avtivity .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-102023
CAS No.: 1227634-69-6
Purity:  99.87%
Research Areas:  

Others

GNF351 is a full aryl hydrocarbon receptor (AHR) antagonist. GNF351 competes with a photoaffinity AHR ligand for binding to the AHR with an IC50 of 62 nM. GNF351 is minimal toxicity in mouse or human keratinocytes .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-112937
CAS No.: 2009273-67-8
Purity:  99.91%
Target:  

Deubiquitinase

Research Areas:  

Cancer

GNE-6640 is a selective and non-covalent inhibitor of ubiquitin epecific peptidase 7 (USP7), with IC50 values of 0.75 μM, 0.43 μM, 20.3 μM and 0.23 μM for full length USP7, USP7 catalytic domain, full length USP47 and Ub-MDM2, respectively .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-10680
CAS No.: 917910-45-3
Purity:  98.06%
Target:  

GPR109A

Research Areas:  

Cancer

MK-6892 is a potent, selective, and full agonist for the high affinity nicotinic acid (NA) receptor GPR109A. Ki and GTPγS EC50 of MK-6892 on the Human GPR109A is 4 nM and 16 nM, respectively.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-112980
CAS No.: 1258984-36-9
Purity:  97.79%
Target:  

DNA/RNA Synthesis

Research Areas:  

Neurological Disease

Nusinersen is an antisense oligonucleotide active molecule. Nusinersen modifies the pre-messenger RNA splicing of the SMN2 gene, thereby promoting the production of full-length SMN protein. Nusinersen improves spinal muscular atrophy .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-112980A
Purity:  98.91%
Target:  

DNA/RNA Synthesis

Research Areas:  

Neurological Disease

Nusinersen sodium is an antisense oligonucleotide active molecule. Nusinersen sodium modifies the pre-messenger RNA splicing of the SMN2 gene, thereby promoting the production of full-length SMN protein. Nusinersen sodium improves spinal muscular atrophy .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-B0659
CAS No.: 59803-98-4
Synonyms: UK 14304; AGN190342
Brimonidine (UK 14304) is a full α2-adrenergic receptor (α2-AR) agonist.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-B0659A
CAS No.: 70359-46-5
Synonyms: UK 14304 tartrate; AGN190342 tartrate
Brimonidine tartrate (UK 14304 tartrate) is a full α2-adrenergic receptor (α2-AR) agonist.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-100653
CAS No.: 1869912-39-9
Purity:  99.20%
Research Areas:  

Cancer

AZD5153 is a bivalent, selective, and orally active BET/BRD4 bromodomain inhibitor with an IC50 of value of 5 nM for full-length BRD4 (FL-BRD4). AZD5153 ligates two bromodomains in BRD4 simultaneously. AZD5153 can be used for the study of cancer, such as acute myeloid leukemia, multiple myeloma, and diffuse large B-cell lymphoma .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N1943
CAS No.: 981-15-7
Synonyms: Δ13-Dehydrochaparrinone
Ailanthone (Δ13-Dehydrochaparrinone) is a potent inhibitor of both full-length androgen receptor (AR) (IC50=69 nM) and constitutively active truncated AR splice variants (AR1-651 IC50=309 nM).
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15827
CAS No.: 7497-07-6
Purity:  99.63%
Target:  

MMP

Research Areas:  

Cardiovascular Disease Cancer

NSC 405020 is a specific MMP14 inhibitor. NSC 405020 can directly interact with the hemopexin domain of MMP14. NSC 405020 reduces the expression of full length and active cleaved Notch3 (NICD3). NSC 405020 can be used to research vestibular schwannoma, hemostasis and thrombosis .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-101299B
CAS No.: 137417-08-4
Purity:  98.89%
Synonyms: DAR-0100 hydrochloride
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Dihydrexidine hydrochloride (DAR-0100 hydrochloride) is a high potent, selective and full efficacy D1-like dopamine receptor (D1/D5) agonist, with an IC50 of 10 nM for D1 receptor. Dihydrexidine hydrochloride exhibits potent antiparkinsonian activity . Dihydrexidine hydrochloride can stimulate YAP phosphorylation .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-138364
CAS No.: 423145-35-1
Purity:  98.01%
Target:  

HSP Apoptosis

Research Areas:  

Cancer

YUM70 is a potent and selective inhibitor of glucose-regulated protein 78 (GRP78), with an IC50 of 1.5 μM for inhibiting GRP78 ATPase activity of the full-length protein. YUM70 induces endoplasmic reticulum (ER) stress-mediated apoptosis in pancreatic cancer. YUM70 also has in vivo efficacy in a pancreatic cancer xenograft model .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15529
CAS No.: 1019331-10-2
Purity:  99.74%
Research Areas:  

Cardiovascular Disease

S0859 is a selective, high-affinity generic Na +/HCO3 - transporter (NBC) inhibitor. S0859 reversibly inhibits NBC-mediated intracellular pH (pHi) recovery (Ki=1.7 μM, full inhibition at approximately 30 μM).
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-B0584
CAS No.: 157283-68-6
Synonyms: Fluprostenol isopropyl ester; AL6221; Flu-Ipr
Travoprost (Fluprostenol isopropyl ester), an isopropyl ester proagent, is a high affinity, selective FP prostaglandin full receptor agonist. Travoprost has the ocular hypotensive efficacy and has the potential for glaucoma and ocular hypertension .
loading...
    loading...